PureTech Health PLC share price logo

PureTech Health PLC

NASDAQ: PRTC

Small Cap

$17.39

+0.13

(+0.75%)

Live

as on

PureTech Health PLC Stock Performance

as on May 14, 2026 at 3:58 am IST

  • Day's Low

    Day's High

    $17.21
    $17.59
    downward going graph

    1.04%

    Downside

    1.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $14.50
    $19.92
    downward going graph

    16.62%

    Downside

    14.55%

    Upside

    downward going graph

PureTech Health PLC share price movements today

Previous Close
$17.26
Open
$17.45
Volume
46.0K
Day's Low - High
$17.21 - $17.59
52 Week Low - High
$14.50 - $19.92

PureTech Health PLC Historical Returns

1 Month Return
-3.06 %
3 Month Return
-1.15 %
1 Year Return
+ 1.53 %
3 Year Return
-38.14 %
5 Year Return
0 %

PureTech Health PLC Stock Fundamentals & Key Indicators

Check PureTech Health PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$424.8M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.61%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-95.2M

Revenue (TTM)

4.7M

Profit Margin

0.00%

Return On Equity TTM

-30.85%

PureTech Health PLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PureTech Health PLC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
PureTech Health PLC image
PureTech Health PLC
BUY$424.8MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for PureTech Health PLC Stock including INR - Dollar returns

The PureTech Health PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

PureTech Health PLC investment value today

Current value as on today

₹1,14,806

Returns

₹14,806

(+14.81%)

Returns from PureTech Health PLC Stock

₹2,294 (+2.29%)

Dollar Impact

₹12,512 (+12.51%)

Analyst Recommendation on PureTech Health PLC Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for PureTech Health PLC. Average target price of $46

PureTech Health PLC Share Price Target

Get share price movements and forecasts by analysts on PureTech Health PLC.

What analysts predicted

62.2%UPSIDE

Target Price

$46

Current Price

$17.39

Analyzed by

6 Analysts

Target

$46.00

PureTech Health PLC target price $46, a slight upside of 62.2% compared to current price of $17.39. According to 6 analysts rating.

Indian Investors' Interest in PureTech Health PLC Stock

Search interest for PureTech Health PLC Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

PureTech Health PLC Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Mar 2026
Total Revenue
4
9
3
0
0
0
4
1
2
Gross Profit
-29
-24
0
-21
-1
-38
42
-23
1
Operating Income
-48
-101
-76
-35
-69
-66
-69
-47
-50
EBITDA
-47
-18
-36
-34
-11
-64
101
-46
-48
Interest Expense
-
2
4
-
8
11
1
0
44
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-18
-25
-8
-11
-22
-55
78
-43
-66
Income Tax Expense
11
-24
11
9
18
-6
2
0
-1
Net Income
-11
-23
-25
-20
-40
-41
95
-44
-64
Net Profit Margin
-256.32%
-256.30%
-793.81%
-22607.22%
-22606.75%
-14504.51%
2366.10%
-2409.78%
-2319.59%

PureTech Health PLC Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
0
16
8
8
9
2
3
4
4
Gross Profit
2
-70
-61
-77
8
-100
-136
-1
1
4
Operating Income
-73
-115
-104
-135
-119
-150
-197
-146
-136
-98
EBITDA
-74
-40
-65
487
62
26
-188
-11
37
-61
Interest Expense
6
10
14
4
2
4
3
13
10
45
Depreciation
-
2
2
6
6
7
8
4
3
3
Income Before Tax
-83
-70
-68
478
18
-58
-92
-36
23
-110
Income Tax Expense
-1
0
2
112
14
3
-55
30
-4
0
Net Income
-48
30
-43
421
5
-60
-50
-65
53
-109
Net Profit Margin
-1101.15%
4749.08%
-266.65%
4847.42%
71.75%
-606.85%
-2409.33%
-1972.88%
1108.33%
-2355.42%

PureTech Health PLC Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Mar 2026
Net Income
-23
-25
-20
-20
-65
-41
69
-44
-64
Operating Cash Flow
-100
-65
-20
-
-39
-80
-53
-46
-38
Investing Cash Flow
-105
173
-
-
-105
236
1
29
33
Financing Cash Flow
-25
91
-6
-
-14
-39
22
-3
-2
Change in Cash
-216
200
-79
-
-159
117
-27
-20
-8

PureTech Health PLC Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-70
-70
366
4
-62
-37
-65
27
-109
Operating Cash Flow
-88
-72
-98
-131
-158
-178
-105
-134
-85
Investing Cash Flow
83
-39
63
364
197
-107
68
240
63
Financing Cash Flow
14
156
49
38
22
-29
78
-16
-6
Change in Cash
9
44
15
271
61
-315
41
89
-28

Global Institutional Holdings in PureTech Health PLC

Funds
Holdings
Pentwater Capital Management LP
0.29%
Millennium Management LLC
0.06%
Atlantic Union Bankshares Corp
0%
Diadema Partners LP
0.03%
Persistent Asset Partners Limited
0.01%
See all

PureTech Health PLC News & Key Events

  • img

    Today's Timeline - 03 November

    Mon, 07:37 PM

    -

    Gallop Oncology reports promising results for LYT-200 in AML trial, showing over 30% complete response rate.

    Tue, 02:41 AM

    -

    PureTech announces LYT-200 data presentation at ASH meeting, highlighting ongoing trial's clinical activity in AML.

Insights on PureTech Health PLC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PRTC stock has moved up by 1.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.85M → 2.79M (in $), with an average increase of 33.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 38.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 70.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 95.28M → -64.88M (in $), with an average decrease of 96.1% per quarter

About PureTech Health PLC

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.
OrganisationPureTech Health PLC
Headquarters6 Tide Street, Boston, MA, United States, 02210
IndustryBiotechnology
CEOMr. Robert Lyne J.D., L.L.B.
E-voting on sharesClick here to vote

Key Management of PureTech Health PLC

Name

Title

Mr. Michael Inbar CPA, M.B.A.

Chief Accounting Officer

Ms. Allison Mead Talbot

Senior VP of Communications & Head of Investor Relations

Ms. Aleksandra Filipovic M.D., Ph.D.

Head of Oncology

Mr. Robert Lyne J.D., L.L.B.

CEO & Director

Dr. Robert S. Langer Jr., Ph.D., ScD

Co-Founder & Non-Executive Director

Dr. Eric Elenko Ph.D.

Co-Founder & President

Dr. David R. Elmaleh Ph.D.

Co-Founder & Senior Advisor

Ms. Lauren A. White M.B.A.

Chief Financial Officer

Mr. Charles Sherwood III, J.D., Ph.D.

General Counsel & Company Secretary

Mr. Spencer Ball

Executive Vice President of Human Resources

FAQs

What is PureTech Health PLC share price today?

PureTech Health PLC share price today is $17.39 as on . PureTech Health PLC share today touched a day high of $17.59 and a low of $17.21.

What is the 52 week high and 52 week low for PureTech Health PLC share?

PureTech Health PLC share touched a 52 week high of $19.92 on and a 52 week low of $14.5 on . PureTech Health PLC stock price today i.e. is trending at $17.39,which is 12.70% down from its 52 week high and 19.93% up from its 52 week low.

What is PureTech Health PLC's market capitalisation today?

PureTech Health PLC market capitalisation is $0.00T as on .

How to invest in PureTech Health PLC Stock (PRTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PureTech Health PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PureTech Health PLC Shares that will get you 0.0863 shares as per PureTech Health PLC share price of $17.39 per share as on May 13, 2026 at 10:28 pm IST.

What is the minimum amount required to buy PureTech Health PLC Stock (PRTC) from India?

Indian investors can start investing in PureTech Health PLC (PRTC) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in PureTech Health PLC stock (as per the Rupee-Dollar exchange rate as on ). Based on PureTech Health PLC share’s latest price of $17.39 as on May 13, 2026 at 10:28 pm IST, you will get 0.5750 shares of PureTech Health PLC. Learn more about fractional shares .